Cargando…
Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia
Chronic kidney disease (CKD) represents a serious concern for the Mexican population since the main predisposing diseases (diabetes, hypertension, etc.) have a high prevalence in the country. The development of frequent comorbidities during CKD such as anemia, metabolic disorders, and hyperphosphate...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693767/ https://www.ncbi.nlm.nih.gov/pubmed/33121062 http://dx.doi.org/10.3390/nu12113289 |
_version_ | 1783614821302796288 |
---|---|
author | Palafox-Serdán, Frida Luna-Montiel, Olinto A. Pablo-Franco, Sebastián E. Guillen-Tejada, Daniela L. Carreño-Vázquez, Sandra D. Silva Pereira, Taísa S. Islas Romero, Laura M. Villaseñor López, Karen Ortega-Régules, Ana E. Jiménez-Garduño, Aura M. |
author_facet | Palafox-Serdán, Frida Luna-Montiel, Olinto A. Pablo-Franco, Sebastián E. Guillen-Tejada, Daniela L. Carreño-Vázquez, Sandra D. Silva Pereira, Taísa S. Islas Romero, Laura M. Villaseñor López, Karen Ortega-Régules, Ana E. Jiménez-Garduño, Aura M. |
author_sort | Palafox-Serdán, Frida |
collection | PubMed |
description | Chronic kidney disease (CKD) represents a serious concern for the Mexican population since the main predisposing diseases (diabetes, hypertension, etc.) have a high prevalence in the country. The development of frequent comorbidities during CKD such as anemia, metabolic disorders, and hyperphosphatemia increases the costs, symptoms, and death risks of the patients. Hyperphosphatemia is likely the only CKD comorbidity in which pharmaceutical options are restricted to phosphate binders and where nutritional management seems to play an important role for the improvement of biochemical and clinical parameters. Nutritional interventions aiming to control serum phosphate levels need to be based on food tables, which should be specifically elaborated for the cultural context of each population. Until now, there are no available food charts compiling a high amount of Mexican foods and describing phosphorus content as well as the phosphate to protein ratio for nutritional management of hyperphosphatemia in CKD. In this work, we elaborate a highly complete food chart as a reference for Mexican clinicians and include charts of additives and drug phosphate contents to consider extra sources of inorganic phosphate intake. We aim to provide an easy guideline to contribute to the implementation of more nutritional interventions focusing on this population in the country. |
format | Online Article Text |
id | pubmed-7693767 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76937672020-11-28 Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia Palafox-Serdán, Frida Luna-Montiel, Olinto A. Pablo-Franco, Sebastián E. Guillen-Tejada, Daniela L. Carreño-Vázquez, Sandra D. Silva Pereira, Taísa S. Islas Romero, Laura M. Villaseñor López, Karen Ortega-Régules, Ana E. Jiménez-Garduño, Aura M. Nutrients Article Chronic kidney disease (CKD) represents a serious concern for the Mexican population since the main predisposing diseases (diabetes, hypertension, etc.) have a high prevalence in the country. The development of frequent comorbidities during CKD such as anemia, metabolic disorders, and hyperphosphatemia increases the costs, symptoms, and death risks of the patients. Hyperphosphatemia is likely the only CKD comorbidity in which pharmaceutical options are restricted to phosphate binders and where nutritional management seems to play an important role for the improvement of biochemical and clinical parameters. Nutritional interventions aiming to control serum phosphate levels need to be based on food tables, which should be specifically elaborated for the cultural context of each population. Until now, there are no available food charts compiling a high amount of Mexican foods and describing phosphorus content as well as the phosphate to protein ratio for nutritional management of hyperphosphatemia in CKD. In this work, we elaborate a highly complete food chart as a reference for Mexican clinicians and include charts of additives and drug phosphate contents to consider extra sources of inorganic phosphate intake. We aim to provide an easy guideline to contribute to the implementation of more nutritional interventions focusing on this population in the country. MDPI 2020-10-27 /pmc/articles/PMC7693767/ /pubmed/33121062 http://dx.doi.org/10.3390/nu12113289 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Palafox-Serdán, Frida Luna-Montiel, Olinto A. Pablo-Franco, Sebastián E. Guillen-Tejada, Daniela L. Carreño-Vázquez, Sandra D. Silva Pereira, Taísa S. Islas Romero, Laura M. Villaseñor López, Karen Ortega-Régules, Ana E. Jiménez-Garduño, Aura M. Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia |
title | Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia |
title_full | Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia |
title_fullStr | Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia |
title_full_unstemmed | Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia |
title_short | Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia |
title_sort | nutritional guideline for the management of mexican patients with ckd and hyperphosphatemia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693767/ https://www.ncbi.nlm.nih.gov/pubmed/33121062 http://dx.doi.org/10.3390/nu12113289 |
work_keys_str_mv | AT palafoxserdanfrida nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia AT lunamontielolintoa nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia AT pablofrancosebastiane nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia AT guillentejadadanielal nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia AT carrenovazquezsandrad nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia AT silvapereirataisas nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia AT islasromerolauram nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia AT villasenorlopezkaren nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia AT ortegaregulesanae nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia AT jimenezgardunoauram nutritionalguidelineforthemanagementofmexicanpatientswithckdandhyperphosphatemia |